RecruitingNCT07339657

Validity and Reliability of the PRAFAB

Evaluation of the Validity and Reliability of the Protection, Amount, Frequency, Compliance, Body Image (PRAFAB) Questionnaire in Women With Urinary Incontinence


Sponsor

Afyonkarahisar Health Sciences University

Enrollment

63 participants

Start Date

Oct 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

PRAFAB assesses both the objective and subjective aspects of urinary incontinence. While differing from other questionnaires in this respect, it consists of only five questions. Today, there is a need for multidimensional and easy-to-use scales that can assess the effects of incontinence on quality of life. Therefore, the aim of this study is to conduct a Turkish validity and reliability study of the PRAFAB questionnaire in women with urinary incontinence.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria3

  • Being 18 years of age or older
  • Have been diagnosed with urinary incontinence by a urologist
  • Be female

Exclusion Criteria3

  • Being pregnant,
  • Being in the early postpartum period,
  • Have been diagnosed with bladder cancer, diabetic nephropathy, a history of central nervous system damage, congenital urological disorders, urinary tract infection, neurogenic bladder, severe cognitive impairment, and severe psychiatric illness.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERConstruct validity

This is not an intervention. This is an analysis conducted to examine the factor structure of this questionnaire. The analysis will be performed using the SPSS 26.0 software package program.

OTHERTest-retest reliability

This is not an intervention. This is an analysis conducted to examine the repeatability of this questionnaire. The analysis will be performed using the SPSS 26.0 software package program.


Locations(1)

Emel Taşvuran Horata

Afyonkarahisar, Merkez, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07339657


Related Trials